Ivabradine - Heart failure
You are here : Home > Formulary Search > Ivabradine - Heart failure
I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.
Status 1
Blue
Formulations :
- Tablets
Formulary Status :
Associated Icons :
Restrictions / Comments :
Important
Restricted to initiation by cardiology only. Transfer of prescribing to primary care only after initiation and at least the first month supply from the specialist.
Documentation
Shared Care
Shared Care
Evidence Review
PAD Profile
ChemicalSubstance :
Ivabradine
Indication :
Heart failure
Group Name :
Keywords :
NICE
Brand Names Include :
Procoralan
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
5
Committee Recommendations (1)
Ivabradine is recommended by the PCN in line with NICE guidance. It would be considered to be suitable as Amber* and an information sheet will be produced for discussion at the PCN in February/ March 2013.
Other Drugs
Below are listed other drugs that are used to treat Heart failure.
- Acetazolamide
- Bisoprolol fumarate
- Candesartan cilexetil
- Captopril
- Carvedilol
- Co-amilozide (Amiloride hydrochloride/hydrochlorot
- Dapagliflozin
- Digoxin
- Empagliflozin
- Enalapril maleate
- Enoximone
- Eplerenone
- Hydralazine hydrochloride
- Levosimendan
- Lisinopril
- Losartan potassium
- Metolazone
- Milrinone lactate
- Nebivolol
- Perindopril erbumine
- Potassium canrenoate
- Prazosin hydrochloride
- Ramipril
- Sacubitril/valsartan
- Spironolactone
- Valsartan